Monthly Journal Club 1st Sunday @2pm covering a range of GI & Hep topics | By @SultanMahmoodMD @ijlalakbar @AtoosaRabiee @AllonKahn @SunilAminMD | #GIJC
🎉 FEATURING Muhammad Ali Butt
📷RECEPIENT 2026 FITE DDW Travel Grant Award!
🏆WINING ABSTRACT: Real-World Impact of the AI Colonoscopy Era on Adenoma Detection and Interval Colorectal Cancer: A National Propensity-Matched Study
#TEUSCONSORTIUM#IDHER#FITE#DDW2026#GRANTS
🆕Now on Preprint: https://t.co/XOPoYFIQZB
Our study comparing the @UCSF secure implementation of @OpenAI gpt-35-turbo #LLM model versus manual chart review for extraction of distinct data elements from #HCC imaging reports
This whole thread is amazing! I wish I had this at the beginning of my training. I probably could have gotten alot more done and in a timely manner. 😁
(Also appreciate #theEmoroidDigest Podcast shoutout 👊👊👊)
📢🥳We are thrilled to welcome @SultanMahmoodMD
to the @UPMC Interventional Endoscopy Team! 🎉 Under the co-leadership of Dr. Mahmood, we now offer ESD and POEM to patients at Passavant, enhancing our commitment to exceptional patient care.
Learn more: https://t.co/KT940JuB9W"
Randomized trial of through-the-skin versus endoscopic liver biopsy
1️⃣equivalent patient satisfaction
2️⃣longer specimen with endoscopy but equivalent portal tracts
3️⃣more fragmentation with endoscopy
https://t.co/Dqv0VIefmT #livertwitter
❓2⃣ Approximately 40% of patients with PBC have inadequate response to ursodeoxycholic acid (UDCA) alone. If a patient does not respond to UDCA, what agent should be considered next?
❓1⃣ Ursodeoxycholic acid (UDCA) remains standard first-line therapy for patients with PBC. Which of the following describes best practice when administering UDCA to patients with PBC?
@my_ueg has come up with this lovely checklist 📑pre #ERCP.
It will be interesting to know🧑🏫
❓️How many ERCPists actually cover all this
❓️Who mentions Mortality 🙋♂️
🤔What's your consent procedure?
@UEGJournal